• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about Psychedelic/Assisted Therapies

    Recent news which mentions Psychedelic/Assisted Therapies

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    14 15 Next >
    Braxia Scientific Faces Challenges In Accessing Public Market Capital, Reports Q1 Loss
    Tickers BRAXF
    Tags Markets Cannabis financial results
    From Benzinga
    Red Light Holland's Q1 2024 Performance: Revenue Soars 53% And Solid Cash Balance
    Tickers TRUFF
    Tags Psilocybin program Markets financial results
    From Benzinga
    Second Psychedelics Merger Of The Week? Silo Wellness To Buy Jamaica-Based Business For $31.9M
    Tickers CYBN DMTTF NUGL SILFF
    Tags Guidance NUGL Market News
    From Benzinga
    Boosting Next-Gen Mental Health Care: Enveric's New US Patent For Anxiety Treatment
    Tickers ENVB
    Tags Cannabis ENVB Markets
    From Benzinga
    Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More
    Tickers ATAI CMPS CYBN DRUG
    Tags IXHL Benzinga CMPS
    From Benzinga
    Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety
    Tickers CYBN DMTTF
    Tags DMTTF CYBN Contracts
    From Benzinga
    Cracking The Code Of Healing: Can Trained Coders Observe Therapeutic Moments In Psilocybin Therapy?
    Tags Benzinga News Psychedelics
    From Benzinga
    Funding The Future Of Psychedelics: Cybin Launches Renewed ATM Equity Program Up To $35M
    Tickers CYBN
    Tags Penny Stocks Market News Financing
    From Benzinga
    GH Research Psychedelics Firm Q2 2023 Reports $238M Cash To Accelerate 5-MeO-DMT Programs Into 2026
    Tickers GHRS
    Tags Management 5/MeO/DMT Market News
    From Benzinga
    Canada Vs. US: Surveys Reveal How People Use Psychedelics, Relationships With Healthcare Providers
    Tags Psychedelic/Assisted Therapies Psychedelics News
    From Benzinga
    Federico Fellini's LSD Journey: How It Inspired Some Of The Greatest Films Of All Time
    Tags Market News Entertainment Federico Fellini
    From Benzinga
    Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports
    Tickers ATAI CMPS CYBN DRUG
    Tags Global Guidance Legal
    From Benzinga
    Psychedelics IP Protection: Cybin Nabs US Patent For Deuterated Analogs, Psilera Advances Next-Gen Library
    Tickers CYBN
    Tags Guidance Next/Generation Psychedelics Market News
    From Benzinga
    $21.8M Revenue For NASDAQ-Listed Psychedelics Ancillary Company Societal CDMO's Q2 2023
    Tickers SCTL
    Tags Benzinga Earnings SCTL
    From Benzinga
    Filament Health Shares Q1 2023 Financials, Material Uncertainties Upon Securing Additional Financing
    Tickers FLHLF JAQC
    Tags financial results Cannabis JAQC
    From Benzinga
    Mydecine Releases Q2 2023: Developer Of Smoke Cessation Psilocybin Prodrugs & MDMA Analogs
    Tickers MYCOF
    Tags Benzinga MYCOF smoke cessation
    From Benzinga
    Cybin's Q1 2023 Financials, Deuterated Psychedelics Moving 'Steadily' Through The Clinic
    Tickers CYBN
    Tags Psychedelic/Assisted Therapies News Psychedelics
    From Benzinga
    Enveric's Q2 2023 Financials Show Immediate Need For Budget-Slimming Toward A Clinical-Staged 2024
    Tickers ENVB
    Tags Benzinga Earnings Markets
    From Benzinga
    MindMed Inks $50M Credit Facility Deal With K2 HealthVentures For An Additional Operational Year
    Tickers MNMD
    Tags Benzinga K2 HealthVentures MNMD
    From Benzinga
    Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
    Tickers AGNPF ATAI AWKNF CMPS
    Tags Benzinga CMPS Small Cap
    From Benzinga
    Multifaceted Artist Kid Cudi Opens Up About Psychedelics, Rehab, Fashion Brand Launch & Being An OG
    Tags Markets Cannabis Benzinga
    From Benzinga
    Atai's Q2 2023 Plus Clinical Data On Ibogaine-Opioid Study, Pipeline's Psilocybin, DMT, Ketamine & MDMA
    Tickers ATAI CMPS
    Tags Psychedelic/Assisted Therapies ATAI Psychedelics
    From Benzinga
    SXSW 2024's Voting Period For 100+ Marijuana & Psychedelics Panels Is On & Upcoming Events Around The Globe
    Tags News Psychedelics Psychedelic/Assisted Therapies
    From Benzinga
    Atai's Clinical Results Of R-Ketamine For Depression: Road To Subcutaneous At-Home Administration
    Tickers ATAI JNJ
    Tags Psychedelics News ATAI
    From Benzinga
    Breaking Ground In Prevention & Relief Of Anxiety & PTSD: Silo Pharma' Nasal Formulation For Ketamine-Based Treatment
    Tickers SILO
    Tags News Psychedelics Psychedelic/Assisted Therapies
    From Benzinga
    Bright Mind Shares Surge 91% After Reporting Positive EEG Clinical Results Of Next-Gen Compound
    Tickers DRUG
    Tags Cannabis clinical trials Markets
    From Benzinga
    First Ever Professional Practice Guidelines For Providing Psychedelic-Assisted Therapy Published
    Tags Benzinga Markets American Psychedelic Practitioners Association
    From Benzinga
    Cybin Closes Short-Lasting Overnight Public Offering With Top Issuance For $8.25M
    Tickers CYBN
    Tags Markets Public Offering Psychedelics Financing
    From Benzinga
    Another Spending Bill Makes Its Way Through Senate, Could Amplify Marijuana & Psychedelics Research
    Tags Legal Psychedelics News
    From Benzinga
    Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More
    Tickers ATAI AWKNF CMPS CYBN
    Tags SEEL PMBHF LSD Microdosing
    From Benzinga
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    14 15 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.